$DJI 0.13% NDX 0.46% SPX 0.26% VIX 1.57% News *
Wed, Sep 18 1:11am

REGN $288.12 2.23 (0.78%)
Regeneron Pharmaceuticals Inc

REGN Profile

Market Cap 31.12 Billion
REGN Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.

Visit Website

REGN Earnings

EPS 1.77 P/E Ratio 24.20
Previous Tue, May 7, 2019
Latest Tue, Aug 6, 2019 (43 days ago) -3.82%

REGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

REGN Charts

1 Year
Sep 9, 2019
Mar 1, 2019

Symbol Price Day Δ YTD Δ
REGN $288.12 0.78% -22.64%


Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy